# KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

> **NCT07563296** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Irma Fleming** · enrollment: 12 (estimated)

## Conditions studied

- PTSD and Trauma-related Symptoms

## Interventions

- **BEHAVIORAL:** Preparatory Session
- **DRUG:** Ketamine-assisted Psychotherapy Session #1
- **DRUG:** Ketamine-assisted Psychotherapy Session #2
- **BEHAVIORAL:** Integration Session

## Key facts

- **NCT ID:** NCT07563296
- **Lead sponsor:** Irma Fleming
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07563296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07563296, "KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07563296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*